Midwest Biomedical Accelerator Consortium (MBArC)

Overview

What they do
Missouri-Columbia, the Midwest Biomedical Accelerator Consortium (MBArC) is an NIH Research Evaluation and Commercialization Hub (REACH) program with a goal to provide funding, training, and education to academic researchers to accelerate the transition of discoveries originating from research labs into products that improve health. P
medicine.missouri.edu
What they look for
The MBArC network will employ the following strategies to increase biomedical research commercialization: Leverage MBArC’s geographic and institutional scope to develop strategic partnerships that invite scientists to engage in technology transfer and commercialization, Give academic researchers the training and resources needed to validate the clinical and commercial feasibility of their innovations, Provide researchers with funding and mentorship to complete product definition studies and attract follow-on funding, and Offer experiential learning opportunities in biomedical entrepreneurship
medicine.missouri.edu
Stage
Ideation, Pre-seed
medicine.missouri.edu
Sectors
Healthcare
medicine.missouri.edu
Based
Columbia, US
medicine.missouri.edu

Sources

2026-08-29medicine.missouri.eduThe Midwest Biomedical Accelerator Consortium (MBArC) was established in 2019 as a 4-year…
2026-08-29medicine.missouri.eduWilliam P. Fay, MD Lead Program Manager

Portfolio, cheque size and the rest

The companies they have backed, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.